ArticleFrontiers in immunology2022
SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma.
Li-Ying OuYang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it